Early Switch in Moderate ARDS (SWITCH-ARDS)
Early Switch to Assisted Ventilation in Patients With Moderate ARDS: a Physiological Study
The optimal timing for transition from controlled to assisted mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) remains uncertain. Excessive spontaneous respiratory effort may promote injurious transpulmonary pressure swings and heterogeneous regional ventilation, whereas unnecessary prolongation of controlled ventilation may increase sedation exposure and diaphragmatic dysfunction.
This prospective, single-center physiological interventional study will enroll mechanically ventilated adults with ARDS and a PaO₂/FiO₂ ratio >100 and ≤200 mmHg, measured during PEEP=5 cmH2O, who are receiving controlled mechanical ventilation. Participants will undergo a protocolized 30-minute transition from controlled to assisted mechanical ventilation after reduction of sedation sufficient to allow spontaneous respiratory activity.
Respiratory effort and drive, airway and esophageal pressures, respiratory flow, respiratory mechanics, gas exchange, and regional ventilation measured by electrical impedance tomography will be assessed before and during the transition. Participants will subsequently be followed for 48 hours to determine whether assisted ventilation can be maintained without return to fully controlled mechanical ventilation.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Participants meeting eligibility criteria will initially remain on their clinically prescribed controlled mechanical ventilation. Sedation will be gradually reduced to permit the reappearance of spontaneous respiratory activity while avoiding clinically significant agitation or patient-ventilator dyssynchrony. Once spontaneous respiratory activity is present, participants will be transitioned to assisted mechanical ventilation. Positive end-expiratory pressure will be maintained at the pre-transition level, which will have been titrated with the use of esophageal manometry so as to achieve an end-expiratory trans-pulmonary pressure above 0 cmH2O, and inspired oxygen fraction will remain unchanged whenever clinically feasible. Inspiratory assistance will be titrated to maintain protective targets: esophageal pressure swings= 3-15 cmH2O (diaphragm protective) and transpulmonary pressure swings < 15-20 cmH2O (lung protective).
The physiological transition trial will last 30 minutes. Continuous recordings of airway pressure, esophageal pressure, respiratory flow, and electrical impedance tomography will be obtained. Respiratory drive will additionally be assessed using airway occlusion pressure at 100 milliseconds (P0.1).
Three prespecified analysis periods will be used: T0, the final 5 minutes during controlled ventilation before transition; T1, the first 5 minutes of assisted ventilation; and T2, minutes 25-30 of assisted ventilation.
Electrical impedance tomography analyses will include regional distribution of tidal ventilation, global inhomogeneity index, end-expiratory lung impedance, ventral-to-dorsal ventilation distribution, center of ventilation, and occurrence or magnitude of pendelluft. Respiratory mechanics analyses will include esophageal pressure swing, pressure-time product of the esophageal pressure, transpulmonary pressure, respiratory system elastance, chest-wall elastance, and lung elastance.
The transition trial will be stopped if prespecified clinical intolerance or safety criteria occur. Participants who do not tolerate the trial will be returned to controlled ventilation according to clinical requirements.
After completion of the 30-minute trial, participants will be followed for 48 hours. Successful transition will be defined as maintenance of assisted mechanical ventilation without the need to return to fully controlled mechanical ventilation during this period.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Apostolos - Alkiviadis Menis, MD, PhD
- Número de teléfono: +30 2413501280
- Correo electrónico: menis.ap.alk@proton.me
Copia de seguridad de contactos de estudio
- Nombre: Demosthenes Makris, MD, PhD
- Número de teléfono: +30 2413501280
- Correo electrónico: dimomakris@med.uth.gr
Ubicaciones de estudio
-
-
-
Larissa, Grecia
- Reclutamiento
- Critical Care Department, University Hospital of Larisa
-
Contacto:
- Apostolos Menis, MD, PhD
- Número de teléfono: +30 2413 501278
- Correo electrónico: menis.ap.alk@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Patients with ARDS of severe to moderate severity (100<PaO2/FiO2<200 mmHg).
Descripción
Inclusion Criteria:
- Age ≥18 years
- Endotracheally intubated and receiving invasive mechanical ventilation
- Meets diagnostic criteria for acute respiratory distress syndrome
- PaO₂/FiO₂ ratio >100 and ≤200 mmHg
- Receiving controlled mechanical ventilation immediately before the transition trial
Exclusion Criteria:
- Implanted electrical cardiac or other device incompatible with electrical impedance tomography
- Thoracic drains, extensive dressings, or other factors preventing appropriate EIT belt placement
- Contraindication to placement of an esophageal balloon catheter
- Active neuromuscular blockade at initiation of the transition trial
- Significant hemodynamic instability
- Any clinical condition for which reduction of sedation or transition to assisted ventilation is considered unsafe by the treating physician
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Protocolized Transition to Assisted Mechanical Ventilation
|
Participants receiving controlled mechanical ventilation will undergo gradual reduction of sedation to permit spontaneous respiratory activity, followed by a 30-minute transition to assisted mechanical ventilation. PEEP will remain at the pre-transition value and FiO₂ will remain unchanged whenever clinically feasible. Inspiratory assistance will be titrated to maintain tidal volume at approximately 6-8 mL/kg predicted body weight. Physiological measurements will be recorded continuously, and the procedure will be terminated if prespecified intolerance or safety criteria occur. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Periodo de tiempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. We will measure respiratory rate (breaths per minute). |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Periodo de tiempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. The measured variables will include the lung elastance, the chest wall elastance and the total respiratory system elastance (all measured in cmH₂O/L). |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Periodo de tiempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. The measured variables will include the transpulmonary pressure, which is measured in cmH₂O. During the baseline measurement both statics and dynamics measurements will be calculated, whereas during the assisted phase the investigator will include only the dynamic measurements. |
During the first thirty minutes of assisted ventilation.
|
|
Difference in Respiratory Mechanics between succesfull and failed transition using a pneumotachograph
Periodo de tiempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the respiratory mechanics at baseline, after the first five minutes of assisted ventilation and at 30 minutes of assisted ventilation. We will measure tidal volume (mLs). |
During the first thirty minutes of assisted ventilation.
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Periodo de tiempo: During the first thirty minutes of assisted ventilation.
|
The investigator will measure the variation in the global inhomogeneity index derived by using electrical impedance tomography. |
During the first thirty minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Periodo de tiempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the end-expiratory lung impedance, EELI, which is measured in ohms. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Periodo de tiempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the ventral to dorsal ratio using the electrical impedance tomography. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in electrical impedance tomography variables between successful and failed transition to assisted ventilation
Periodo de tiempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the variation in the pendelluft phenomenon using the impedance amplitude values. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in respiratory effort between successful and failed transition to assisted ventilation
Periodo de tiempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the differences in esophageal pressure swings, ΔPes in cmH₂O, between the beginning of the transition phase and at the final 5 minutes of the 30-minute trial. |
During the first 30-minutes of assisted ventilation.
|
|
Differences in respiratory effort between successful and failed transition to assisted ventilation.
Periodo de tiempo: During the first 30-minutes of assisted ventilation.
|
The investigator will measure the differences in the esophageal pressure-time product measured in cmH₂O⋅s/min, between the beginning of the transition phase and at the final 5 minutes of the 30-minute trial. |
During the first 30-minutes of assisted ventilation.
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Apostolos - Alkiviadis Menis, MD, PhD, General University Hospital of Larisa, University of Thessaly
- Director de estudio: Makris, MD, PhD, General University Hospital of Larisa, University of Thessaly
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- SWITCH_MODERATE_ARDS
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .